Characteristic | Proportion Expecting Antibiotics, %a | aOR (95% CI) | P Value |
---|---|---|---|
Group | |||
Control | 39 | Ref | … |
Futility | 40 | 0.58 (0.35-0.95) | .03 |
Adverse effects | 39 | 0.44 (0.26-0.74) | <.01 |
Sex | |||
Female | 36 | Ref | … |
Male | 48 | 1.75 (1.12-2.74) | .02 |
Age-group | |||
Adult | 40 | Ref | … |
Childb | 39 | 0.72 (0.44-1.18) | .19 |
Predominant symptoms | |||
Sore throat | |||
No | 39 | Ref | … |
Yes | 39 | 1.62 (1.06-2.48) | .03 |
Cough | |||
No | 33 | Ref | … |
Yes | 42 | 1.30 (0.81-2.11) | .28 |
Earache | |||
No | 38 | Ref | … |
Yes | 44 | 1.28 (0.79-2.09) | .32 |
Symptom severityc | … | 1.16 (0.91-1.47) | .22 |
Degree of concernc | … | 1.15 (0.96-1.37) | .13 |
aOR = adjusted odds ratio; Ref = reference.
Note: Assessed after participants viewed 1 of the presentations, with the postpresentation questionnaire.
↵a Unadjusted.
↵b Parents provided response for children aged 0 to 7 years presenting with symptoms of upper respiratory tract infection.
↵c Measured on a 7-point scale where higher score indicates greater severity or concern.